Stacy Lindborg

Stacy Lindborg

Company: BrainStorm Cell Therapeutics

Job title: Former Co-Chief Executive Officer


Promising Longer-Term Biomarker Data from NurOwn Program in ALS: Spotlight on NfL in EAP Extension Cohort 9:00 am

CSF samples were drawn during Phase 3 trial (3 treatments, debamestrocel and Placebo) and in participants who continued into EAP (6 treatments, debamestrocel) Trials enable hypothesis-generating data of the impact on a key marker of neuronal death related to longer-term treatment with an autologous cell therapy and the impact of delayed start to treatment Results…Read more

day: Conference Day One Morning

A Hanson Wade Group Company

© Copyright 2024 Hanson Wade | Design and site by Event Engine | Hanson Wade Limited is registered in England & Wales, number 06752216.
Registered Office: Eastcastle House, 27/28 Eastcastle Street, London, W1W 8DH.